450.2000 1.85 (0.41%)
NSE Mar 20, 2026 15:31 PM
Volume: 67,246
 

450.20
0.41%
Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Promoters unpledged 9.28% of shares in last quarter. Total pledge stands at 26.04% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended